Postmenopausal women with Type 2 diabetes may improve some symptoms with the use of safflower cooking oil, according to Ohio State University researchers. The researchers found that women who include about one and two-third teaspoons of safflower cooking oil to their diets may improve their cholesterol, blood sugar, insulin sensitivity, …
Read More »Cocoa Rich in Health Benefits
Harvard researchers suggest that cocoa may have significant health benefits. The researchers analyzed 21 studies with 2,575 participants and found that cocoa consumption is associated with improved blood vessel health, cholesterol levels, and blood pressure. The apparent benefits, according to Eric L. Ding, of Harvard Medical School, are from polyphenolic …
Read More »Diabetes Is Linked to Premature Death from Many Causes in Addition to Vascular Disease
The presence of diabetes mellitus approximately doubles the risk of a wide range of vascular diseases according to the study. Evidence is also emerging that diabetes is associated with nonvascular conditions. Fasting glucose levels of more than 100 mg/dL (5.6 mmol/L) were associated with death, but levels of 70 to …
Read More »California, Texas and Florida Are the Nation’s Top Diabetes Hot Spots
These states will bear many of the costs of a growing diabetes epidemic in the next 15 years. By 2025, one out of seven Americans will have diabetes — a 64% increase from 2010, according to an analysis conducted by the Institute for Alternative Futures and funded by Novo Nordisk. …
Read More »Women with Gestational Diabetes Fall through the Cracks
Women with a history of GDM have an increased risk of developing Type 2 diabetes, but often do not return for follow-up care. Researchers conducted 22 semi-structured interviews. Mean age was 31.5 years, 63% were nonwhite, mean body mass index (BMI) was 25.9 kg/m(2), and 82% attended a postpartum visit. …
Read More »Amylin & Takeda suspended the study of pramlintide/metreleptin for obesity
Amylin Pharmaceuticals and Takeda Pharmaceutical announced that they have suspended clinical activities in an ongoing Phase 2 study examining the safety and effectiveness of the investigational combination therapy pramlintide/metreleptin for the treatment of obesity. The clinical study was voluntarily halted to investigate a new antibody-related laboratory finding with metreleptin treatment …
Read More »What Is the Diabetes Belt?
The Southeastern US has been dubbed the “diabetes belt” with 644 mostly southern counties presenting above average rates of diabetes, according to new research by the CDC. There are more than 18 million diabetes sufferers nationwide, with a state pattern emerging for overall averages that matches known risk factors like …
Read More »Coffee May Lower Stroke Risk for Women
Women who drink more than one cup of coffee a day could reduce their risk of stroke by 22% to 25%. A new study followed 34,670 Swedish women, ages 49 to 83, for an average of 10.4 years. Women who reported drinking little or no coffee had a higher risk …
Read More »Soy Not Effective on Glycemic Control
Previous studies have suggested that soy intake may carry beneficial effects on glycemic control, but human intervention studies have yielded mixed results. A recent meta-analysis of 24 trials and more than 1,500 subjects found that soy consumption does not significantly affect measures of glycemic control. Researchers noted that there was …
Read More »Newsflash: The FDA has accepted Bristol-Myers Squibb’s New Drug Application for dapagliflozin
The FDA has accepted Bristol-Myers Squibb’s New Drug Application for its first in class drug dapagliflozin, an investigational selective sodium-glucose cotransporter-2 inhibitor (SGLT2), first in class compound for the treatment of adults with Type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.